Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation

Tsunehiro Takahashi, Yoshiro Saikawa, Tetsuro Kubota, Yasutada Akiba, Naoyuki Shigematsu, Masashi Yoshida, Yoshihide Otani, Koichiro Kumai, Toshifumi Hibi, Masaki Kitajima

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A 76-year-old male was diagnosed with stage IV (cT4, cN2, cP0, cH0, cM0) gastric carcinoma with a type 3 tumor in the cardia with lymph node metastases, determined by gastrofiberscope and abdominal computed tomography (CT). The patient was treated with chemotherapy consisting of S-1 and low-dose cisplatin (CDDP) during the first cycle (3 weeks). S-1 was orally administered at a dose of 100 mg/day (60 mg/m2/ day) on days 1-21. CDDP was infused at a dose of 10 mg/day (6 mg/ m2/day) on days 1-5, 8-12 and 15-19. After this cycle, the clinical response was evaluated as no change (NC). In the second cycle, radiation therapy (2 Gy/day for 5 days/week) was initiated along with the chemotherapy. The CDDP dose was decreased to 7.5 mg/day because of the grade 3 thrombocytopenia and grade 2 leukocytopenia that occurred during the first cycle. The second cycle was stopped at a total radiation dose of 48 Gy due to grade 3 thrombocytopenia and grade 2 leukocytopenia. Examination after this treatment showed remarkable reduction of tumor volume in the primary lesion and lymph nodes, which was defined as a partial response (PR). The patient then underwent total gastrectomy with D1 lymph node dissection. The postoperative course was uneventful without surgical complications. At this time, no gastric cancer cells were detected in the resected specimen, including the primary lesion and lymph nodes, confirming a pathological complete response (CR grade 3). Thus, the chemo-radiation treatment regimen described here may be a potent tool to control advanced gastric carcinoma.

Original languageEnglish
Pages (from-to)584-588
Number of pages5
JournalJapanese Journal of Clinical Oncology
Volume33
Issue number11
DOIs
Publication statusPublished - 2003 Nov 1

Fingerprint

Cisplatin
Stomach Neoplasms
Lymph Nodes
Leukopenia
Radiation
Drug Therapy
Stomach
Carcinoma
Cardia
Gastrectomy
Tumor Burden
Lymph Node Excision
Radiotherapy
Tomography
Neoplasm Metastasis
Therapeutics
Neoplasms
Thrombocytopenia chromosome breakage

Keywords

  • Cisplatin
  • Complete response
  • Gastric cancer
  • Radiation
  • S-1

ASJC Scopus subject areas

  • Oncology

Cite this

Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation. / Takahashi, Tsunehiro; Saikawa, Yoshiro; Kubota, Tetsuro; Akiba, Yasutada; Shigematsu, Naoyuki; Yoshida, Masashi; Otani, Yoshihide; Kumai, Koichiro; Hibi, Toshifumi; Kitajima, Masaki.

In: Japanese Journal of Clinical Oncology, Vol. 33, No. 11, 01.11.2003, p. 584-588.

Research output: Contribution to journalArticle

Takahashi, Tsunehiro ; Saikawa, Yoshiro ; Kubota, Tetsuro ; Akiba, Yasutada ; Shigematsu, Naoyuki ; Yoshida, Masashi ; Otani, Yoshihide ; Kumai, Koichiro ; Hibi, Toshifumi ; Kitajima, Masaki. / Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation. In: Japanese Journal of Clinical Oncology. 2003 ; Vol. 33, No. 11. pp. 584-588.
@article{8355fb99abca4aee85591f88d59c8749,
title = "Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation",
abstract = "A 76-year-old male was diagnosed with stage IV (cT4, cN2, cP0, cH0, cM0) gastric carcinoma with a type 3 tumor in the cardia with lymph node metastases, determined by gastrofiberscope and abdominal computed tomography (CT). The patient was treated with chemotherapy consisting of S-1 and low-dose cisplatin (CDDP) during the first cycle (3 weeks). S-1 was orally administered at a dose of 100 mg/day (60 mg/m2/ day) on days 1-21. CDDP was infused at a dose of 10 mg/day (6 mg/ m2/day) on days 1-5, 8-12 and 15-19. After this cycle, the clinical response was evaluated as no change (NC). In the second cycle, radiation therapy (2 Gy/day for 5 days/week) was initiated along with the chemotherapy. The CDDP dose was decreased to 7.5 mg/day because of the grade 3 thrombocytopenia and grade 2 leukocytopenia that occurred during the first cycle. The second cycle was stopped at a total radiation dose of 48 Gy due to grade 3 thrombocytopenia and grade 2 leukocytopenia. Examination after this treatment showed remarkable reduction of tumor volume in the primary lesion and lymph nodes, which was defined as a partial response (PR). The patient then underwent total gastrectomy with D1 lymph node dissection. The postoperative course was uneventful without surgical complications. At this time, no gastric cancer cells were detected in the resected specimen, including the primary lesion and lymph nodes, confirming a pathological complete response (CR grade 3). Thus, the chemo-radiation treatment regimen described here may be a potent tool to control advanced gastric carcinoma.",
keywords = "Cisplatin, Complete response, Gastric cancer, Radiation, S-1",
author = "Tsunehiro Takahashi and Yoshiro Saikawa and Tetsuro Kubota and Yasutada Akiba and Naoyuki Shigematsu and Masashi Yoshida and Yoshihide Otani and Koichiro Kumai and Toshifumi Hibi and Masaki Kitajima",
year = "2003",
month = "11",
day = "1",
doi = "10.1093/jjco/hyg110",
language = "English",
volume = "33",
pages = "584--588",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation

AU - Takahashi, Tsunehiro

AU - Saikawa, Yoshiro

AU - Kubota, Tetsuro

AU - Akiba, Yasutada

AU - Shigematsu, Naoyuki

AU - Yoshida, Masashi

AU - Otani, Yoshihide

AU - Kumai, Koichiro

AU - Hibi, Toshifumi

AU - Kitajima, Masaki

PY - 2003/11/1

Y1 - 2003/11/1

N2 - A 76-year-old male was diagnosed with stage IV (cT4, cN2, cP0, cH0, cM0) gastric carcinoma with a type 3 tumor in the cardia with lymph node metastases, determined by gastrofiberscope and abdominal computed tomography (CT). The patient was treated with chemotherapy consisting of S-1 and low-dose cisplatin (CDDP) during the first cycle (3 weeks). S-1 was orally administered at a dose of 100 mg/day (60 mg/m2/ day) on days 1-21. CDDP was infused at a dose of 10 mg/day (6 mg/ m2/day) on days 1-5, 8-12 and 15-19. After this cycle, the clinical response was evaluated as no change (NC). In the second cycle, radiation therapy (2 Gy/day for 5 days/week) was initiated along with the chemotherapy. The CDDP dose was decreased to 7.5 mg/day because of the grade 3 thrombocytopenia and grade 2 leukocytopenia that occurred during the first cycle. The second cycle was stopped at a total radiation dose of 48 Gy due to grade 3 thrombocytopenia and grade 2 leukocytopenia. Examination after this treatment showed remarkable reduction of tumor volume in the primary lesion and lymph nodes, which was defined as a partial response (PR). The patient then underwent total gastrectomy with D1 lymph node dissection. The postoperative course was uneventful without surgical complications. At this time, no gastric cancer cells were detected in the resected specimen, including the primary lesion and lymph nodes, confirming a pathological complete response (CR grade 3). Thus, the chemo-radiation treatment regimen described here may be a potent tool to control advanced gastric carcinoma.

AB - A 76-year-old male was diagnosed with stage IV (cT4, cN2, cP0, cH0, cM0) gastric carcinoma with a type 3 tumor in the cardia with lymph node metastases, determined by gastrofiberscope and abdominal computed tomography (CT). The patient was treated with chemotherapy consisting of S-1 and low-dose cisplatin (CDDP) during the first cycle (3 weeks). S-1 was orally administered at a dose of 100 mg/day (60 mg/m2/ day) on days 1-21. CDDP was infused at a dose of 10 mg/day (6 mg/ m2/day) on days 1-5, 8-12 and 15-19. After this cycle, the clinical response was evaluated as no change (NC). In the second cycle, radiation therapy (2 Gy/day for 5 days/week) was initiated along with the chemotherapy. The CDDP dose was decreased to 7.5 mg/day because of the grade 3 thrombocytopenia and grade 2 leukocytopenia that occurred during the first cycle. The second cycle was stopped at a total radiation dose of 48 Gy due to grade 3 thrombocytopenia and grade 2 leukocytopenia. Examination after this treatment showed remarkable reduction of tumor volume in the primary lesion and lymph nodes, which was defined as a partial response (PR). The patient then underwent total gastrectomy with D1 lymph node dissection. The postoperative course was uneventful without surgical complications. At this time, no gastric cancer cells were detected in the resected specimen, including the primary lesion and lymph nodes, confirming a pathological complete response (CR grade 3). Thus, the chemo-radiation treatment regimen described here may be a potent tool to control advanced gastric carcinoma.

KW - Cisplatin

KW - Complete response

KW - Gastric cancer

KW - Radiation

KW - S-1

UR - http://www.scopus.com/inward/record.url?scp=1342310686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342310686&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyg110

DO - 10.1093/jjco/hyg110

M3 - Article

C2 - 14711984

AN - SCOPUS:1342310686

VL - 33

SP - 584

EP - 588

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 11

ER -